Elizabeth R. Tucker et al.
Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Clinical Cancer Research 2023, vol. 29, issue 7
doi: 10.1158/1078-0432.ccr-22-2274